Arcutis Biotherapeutics Inc (NAS:ARQT)
$ 10.25 -0.59 (-5.44%) Market Cap: 1.20 Bil Enterprise Value: 1.15 Bil PE Ratio: 0 PB Ratio: 7.65 GF Score: 29/100

Arcutis Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 06:55PM GMT
Release Date Price: $8.19 (+5.13%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Okay. All right. Welcome, everyone. This is the fireside chat with our Arcutis Biotherapeutics. My name is Vikram Purohit. I'm one of the biotech analysts with the research team. Thanks for joining us.

Before we get started, I need to read a brief disclosure statement for important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

With that, happy to have with me Frank and Patrick from Arcutis. Thanks for joining us.

Todd Franklin Watanabe
Arcutis Biotherapeutics, Inc. - President, CEO & Director

Thanks.

Questions & Answers

Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Quite a lot to cover in roughly 30 minutes, but Frank, I wanted to turn it over to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot